Skip to main content

Table 3 Effect size estimates for comparisons and secondary outcomes included in the meta-analysis

From: Effects of supervised exercise on cancer-related fatigue in breast cancer survivors: a systematic review and meta-analysis

Outcome

Effect size random effects model –SMD* (95%CI)

Statistical heterogeneity (I2)

Primary outcome (CRF)

Supervised aerobic exercise

−0.51, 95%CI [−0.81, −021], (P = 0.001) †

75%

Supervised resistance training

−0.41, 95%CI [−0.76, −0.05], (P = 0.02) †

64%

Supervised exercise during active anti-cancer treatment

−0.66, 95%CI [−1.08, −0.23], (P = 0.002) †

78.6%

Supervised exercise after anti-cancer treatment

−0.25, 95%CI [−0.55, 0.05], (P = 0.10)

85.8%

Secondary outcomes

Depression

−0.23, 95%CI [−0.55, 0.09], (P = 0.16)

69%

Body mass index

−0.14, 95%CI [−0.38, 0.11], (P = 0.28)

0%

Physical activity level

1.10, 95%CI [−0.41, 2.62], (P = 0.15)

85%

Health-related quality of life

Physical wellbeing

0.63, 95%CI [0.08, 1.18], (P = 0.02) †

89%

Functional wellbeing

0.60, 95%CI [0.08, 1.11], (P = 0.02) †

89%

Social wellbeing

0.08, 95%CI [−0.11, 0.27], (P = 0.24)

28%

Emotional wellbeing

0.30, 95%CI [−0.05, 0.65], (P = 0.09)

76%

  1. *Standarized mean difference.
  2. † Significant differences observed (P < 0.05).
  3. Cancer-related fatigue, CRF.